Boostrix tdap vaccine syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BCN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,405
Award facts
- Contract value 100% obligated
- $1,405.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,405.47 to supply Boostrix TDAP vaccine in 0.5ML syringes. This non-set-aside, competitively awarded contract has a firm fixed price structure with an ultimate completion date of December 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through this comprehensive IDC, which functions as a global pharmaceutical support vehicle. The parent contract enables the company to supply a broad range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The Boostrix TDAP vaccine delivery under this award supports continued immunization supply requirements for federal healthcare operations. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts, with anticipated multiple awards across separate regions, demonstrating the strategic importance of vaccine and pharmaceutical procurement for military readiness.
Quick answers
Who was awarded contract SPE2DR26F9BCN?
SPE2DR26F9BCN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F9BCN worth?
The government has obligated $1,405 on SPE2DR26F9BCN.
Is contract SPE2DR26F9BCN an order under another contract?
Yes. SPE2DR26F9BCN is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BCN competed?
The extent of competition for SPE2DR26F9BCN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award